Cyclerion Therapeutics Inc
NASDAQ:CYCN
Net Margin
Cyclerion Therapeutics Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | US |
Market Cap | 7.1m USD |
Net Margin | N/A |
Country | US |
Market Cap | 290.3B USD |
Net Margin |
9%
|
Country | US |
Market Cap | 168.9B USD |
Net Margin |
13%
|
Country | US |
Market Cap | 113.4B USD |
Net Margin |
37%
|
Country | US |
Market Cap | 106.7B USD |
Net Margin |
29%
|
Country | AU |
Market Cap | 138.6B AUD |
Net Margin |
17%
|
Country | US |
Market Cap | 84.6B USD |
Net Margin |
2%
|
Country | US |
Market Cap | 50.9B USD |
Net Margin |
-116%
|
Country | US |
Market Cap | 43.1B USD |
Net Margin |
-33%
|
Country | US |
Market Cap | 33.5B USD |
Net Margin |
12%
|
Country | KR |
Market Cap | 40T KRW |
Net Margin |
25%
|
Profitability Report
View the profitability report to see the full profitability analysis for Cyclerion Therapeutics Inc.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Cyclerion Therapeutics Inc's most recent financial statements, the company has Net Margin of 0%.